Portfolio return of 46.7% beat benchmark by 8.9pp, NTA up 24.3%

That portfolio return drove net tangible assets per share from $1.03 to $1.28, a lift of 24.3%, and grew net assets attributable to shareholders by 56.5% to $244.4m.

The income statement reflected the same dynamic. Total investment return (net gains plus dividend and interest income) rose 189.8% to $78.1m, NPAT grew 206.2% to $69.2m, and profit before tax was up 216.4% at $71.5m. The headline result is described by the company as a record.

Cash distributed to shareholders during the year totalled around $9.6m and the board declared a final dividend of 2.52 cents per share, taking the full-year dividend to 8.84 cents (FY20: 2.06 cents on the basis supplied).

Realised plus unrealised net gains on investments of roughly $77.3m account for the overwhelming majority of FY21 investment income, while recurring dividend and interest income was just $0.6m, slightly below FY20's $0.7m. This matters because the read on FY21 is principally a read on market beta and stock selection within Marlin's mandate, not a step-change in the underlying yield of the portfolio.

Active outperformance is the genuine quality signal. The 8.9pp gap between the 46.7% portfolio return and the 37.8% benchmark return is the cleanest evidence that the manager added value above market direction. NTA per share growth of 24.3% and ROE of 28.3% (FY20: 14.4%) reflect that combined effect.

Distribution capacity now depends on continued portfolio gains. Recurring investment income of $0.6m covers only a small fraction of the $9.6m distributed, so the sustainability of the current distribution rate is tied to realising portfolio gains rather than to a recurring income stream. The implication is that distribution levels will be more sensitive to market drawdowns than headline coverage on NPAT suggests.

HY21 contributed 41.3% of full-year investment income and 37.4% of full-year NPAT, implying a stronger second half of roughly $43.3m of NPAT and $45.8m of investment income. That shape is consistent with continued portfolio appreciation in the second half rather than a normalised run-rate.

Because the underlying driver is portfolio return rather than recurring earnings, prior-year repeatability is not a useful base case. The relevant forward question is whether the 8.9pp benchmark outperformance can be sustained, not whether the 46.7% absolute return can be repeated.

The release frames the result as $77.3m of net gains on investments without isolating the realised component, which means the reader cannot tell from this release how much of the $69.2m NPAT is locked-in cash versus mark-to-market. NTA per share growth of 24.3% and a 56.5% lift in net assets are the cleaner reads on shareholder value created in the period.

Operating cash flow of -$16.6m versus +$6.7m in FY20 is a function of portfolio acquisition and disposal timing rather than earnings quality in the operating-company sense, so it should not be read as a cash-conversion concern. However, with cash on hand of only $5.1m against $9.6m of distributions paid, the company is materially reliant on portfolio realisations to fund distributions, and that reliance is the clearest quality caveat on the headline NPAT.

This briefing cannot assess the realised-versus-unrealised composition of investment gains, forward portfolio positioning, or the formal mechanics of the distribution policy because those details are not in the supplied release content.